151 related articles for article (PubMed ID: 15272191)
1. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.
Evans HR; Holloway DE; Sutton JM; Ayriss J; Shone CC; Acharya KR
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1502-5. PubMed ID: 15272191
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.
Holbourn KP; Sutton JM; Evans HR; Shone CC; Acharya KR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5357-62. PubMed ID: 15809419
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme.
Pautsch A; Vogelsgesang M; Tränkle J; Herrmann C; Aktories K
EMBO J; 2005 Oct; 24(20):3670-80. PubMed ID: 16177825
[TBL] [Abstract][Full Text] [Related]
6. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
Xiao JF; Li ZS; Sun CC
Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
[TBL] [Abstract][Full Text] [Related]
8. Structure and action of the binary C2 toxin from Clostridium botulinum.
Schleberger C; Hochmann H; Barth H; Aktories K; Schulz GE
J Mol Biol; 2006 Dec; 364(4):705-15. PubMed ID: 17027031
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD.
Evans HR; Sutton JM; Holloway DE; Ayriss J; Shone CC; Acharya KR
J Biol Chem; 2003 Nov; 278(46):45924-30. PubMed ID: 12933793
[TBL] [Abstract][Full Text] [Related]
10. Conformational plasticity is crucial for C3-RhoA complex formation by ARTT-loop.
Tsuge H; Yoshida T; Tsurumura T
Pathog Dis; 2015 Dec; 73(9):ftv094. PubMed ID: 26474844
[TBL] [Abstract][Full Text] [Related]
11. Rho-modifying C3-like ADP-ribosyltransferases.
Aktories K; Wilde C; Vogelsgesang M
Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
[TBL] [Abstract][Full Text] [Related]
12. Structural constraints-based evaluation of immunogenic avirulent toxins from Clostridium botulinum C2 and C3 toxins as subunit vaccines.
Prisilla A; Prathiviraj R; Sasikala R; Chellapandi P
Infect Genet Evol; 2016 Oct; 44():17-27. PubMed ID: 27320793
[TBL] [Abstract][Full Text] [Related]
13. NAD binding induces conformational changes in Rho ADP-ribosylating clostridium botulinum C3 exoenzyme.
Ménétrey J; Flatau G; Stura EA; Charbonnier JB; Gas F; Teulon JM; Le Du MH; Boquet P; Menez A
J Biol Chem; 2002 Aug; 277(34):30950-7. PubMed ID: 12029083
[TBL] [Abstract][Full Text] [Related]
14. Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cells.
Rohrbeck A; von Elsner L; Hagemann S; Just I
Toxins (Basel); 2015 Feb; 7(2):380-95. PubMed ID: 25648844
[TBL] [Abstract][Full Text] [Related]
15. Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Williamson KC; Smith LA; Moss J; Vaughan M
Trans Assoc Am Physicians; 1990; 103():281-8. PubMed ID: 2132538
[No Abstract] [Full Text] [Related]
16. NAD+ binding site of Clostridium botulinum C3 ADP-ribosyltransferase. Identification of peptide in the adenine ring binding domain using 2-azido NAD.
Chavan AJ; Nemoto Y; Narumiya S; Kozaki S; Haley BE
J Biol Chem; 1992 Jul; 267(21):14866-70. PubMed ID: 1634527
[TBL] [Abstract][Full Text] [Related]
17. Identification of Glu173 as the critical amino acid residue for the ADP-ribosyltransferase activity of Clostridium botulinum C3 exoenzyme.
Saito Y; Nemoto Y; Ishizaki T; Watanabe N; Morii N; Narumiya S
FEBS Lett; 1995 Sep; 371(2):105-9. PubMed ID: 7672106
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a neutralizing monoclonal antibody against botulinum ADP-ribosyltransferase, C3 exoenzyme.
Kamata Y; Hoshi H; Choki H; Kozaki S
J Vet Med Sci; 2002 Sep; 64(9):767-71. PubMed ID: 12399599
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.
Ménétrey J; Flatau G; Boquet P; Ménez A; Stura EA
Protein Sci; 2008 May; 17(5):878-86. PubMed ID: 18369192
[TBL] [Abstract][Full Text] [Related]
20. Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.
Böhmer J; Jung M; Sehr P; Fritz G; Popoff M; Just I; Aktories K
Biochemistry; 1996 Jan; 35(1):282-9. PubMed ID: 8555186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
